Research and Markets: Diabetic Foot Infection (DFI) Pipeline Insights Report 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/gch5h4/diabetic_foot) has announced the addition of the "Diabetic Foot Infection (DFI)-Pipeline Insights" report to their offering.

Diabetic Foot Infection (DFI) Pipeline Insights provides the in-depth analysis of the pipeline assets across the Diabetic Foot Infection (DFI). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Diabetic Foot Infection (DFI) Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

Diabetic Foot Infection (DFI) Pipeline Insights Report covers the Diabetic Foot Infection (DFI) pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Diabetic Foot Infection (DFI) related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Diabetic Foot Infection (DFI).

Scope

- The report provides a Diabetic Foot Infection (DFI) Landscape across the globe

- The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information

- Coverage of the Diabetic Foot Infection (DFI) pipeline on the basis of target, MOA, route of administration, technology involved and molecule type

- The report reviews key players involved in the therapeutics development for Diabetic Foot Infection (DFI) and also provide company profiling

- Pipeline products coverage based on various stages of development from NDA filings to discovery.

- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

For more information visit http://www.researchandmarkets.com/research/gch5h4/diabetic_foot

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals